Φόρτωση

Slzii.com Αναζήτηση

Αναζήτηση (Νέα)

Biohaven collaborates with SK Pharmaceuticals on Opakalim to treat focal epilepsy

Healthcaremea english health top

Biohaven is currently evaluating the therapy in the Phase II/III RISE3 study, with results expected in the second half of 2026.
2026-08-28 07:34:52

Τι κάνεις;
0.036419868469238


Νέα
Healthcaremea

Τελευταίες ειδήσεις και τίτλοι
Biohaven is currently evaluating the therapy in the Phase II/III RISE3 study, with results expected in the second half of 2026.
Νέα